The First Affiliated Hospital Of Zhengzhou University

This study tests a new drug, IBI363, combined with standard medicines for people with advanced stomach cancer that got worse after initial treatment. The goal is to see if the combination is safe and can shrink tumors or slow the disease. About 50 adults aged 18 to 75 will take p…

This study tests whether the clot-busting drug tenecteplase can help people who have an ischemic stroke and are treated 4.5 to 9 hours after symptoms start. About 564 adults will be randomly assigned to receive either tenecteplase or a placebo, along with standard care. The goal …

This study tests a combination of two drugs (sacituzumab tirumotecan and bevacizumab) in 30 women with platinum-resistant recurrent ovarian cancer, a type that no longer responds to standard chemotherapy. The goal is to see if the combo can shrink tumors and delay cancer growth. …

This phase 3 trial tests whether a new combination of drugs (anlotinib plus benmelstobart) works better than the current standard treatment for advanced esophageal cancer that has certain gene mutations. About 578 adults with this cancer who have not had prior treatment will be r…

This study tests a new rinse solution used during colonoscopy. The rinse combines menthol (from peppermint oil) to relax the colon and simethicone to clear foam, which may help doctors see polyps more clearly. About 500 adults getting a colonoscopy will be randomly assigned to re…

This study tests whether spraying a menthol solution into the colon during a colonoscopy can reduce muscle spasms and help doctors find more polyps. About 440 adults getting a colonoscopy will be randomly assigned to receive either menthol or a placebo rinse. The goal is to see i…

This study tests whether combining two therapies—blood flow restriction training (using a cuff to partially restrict arm blood flow during exercise) and repetitive transcranial magnetic stimulation (a non-invasive brain stimulation)—can improve arm and leg function in people who …